- Home
- BTAI vs MGN Comparison
BTAI vs MGN Comparison
Compare BTAI & MGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTAI | MGN |
|---|---|---|
| Founded | 2017 | 2020 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 43.0M |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | BTAI | MGN |
|---|---|---|
| Price | $1.87 | $1.91 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 540.0K | 41.4K |
| Earning Date | 11-12-2025 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | $752,000.00 | ★ $13,484,571.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $416.40 | N/A |
| P/E Ratio | ★ N/A | $26.63 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.17 | $1.30 |
| 52 Week High | $9.26 | $8.63 |
Technical Indicators
Market Signals| Indicator | BTAI | MGN |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | N/A |
| Support Level | $1.82 | N/A |
| Resistance Level | $2.30 | N/A |
| Average True Range (ATR) | 0.15 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 5.83 | 0.00 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About MGN Megan Holdings Limited Ordinary Shares
Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.